Chronic Lymphocytic Leukemia research at #ASH22: Dana-Farber's Matthew Davids, MD @DrMDavids
Watch a video of Dr. Davids comments about the effectiveness of this treatment combination for patients with high-risk CLL.
https://twitter.com/DanaFarber/status/1601703367750942724?s=20&t=YfMDLAvEZ7-sfqxw1fJrtg
